| Literature DB >> 24188659 |
Jifang Dai, Lianyi Zhao, Yuan Liang1.
Abstract
To view methadone maintenance treatment (MMT) globally, it is necessary to accumulate data on MMT policy implementation under different health service systems. The aim of the current study is to provide empirical evidence about policy implementation of MMT and HIV infection control, as well as recommendations for improvement of MMT in the future. Based on China's national policy framework of MMT, policy implementation of MMT in Hubei province has two objectives: 1) to create linkages between health and public security, and 2) to provide integrated services for management of drug abusers. From 2007 to 2011, following the establishment of MMT clinics that provide methadone as well as HIV prevention services, the proportion of HIV infection among drug abusers decreased relatively quickly (12.12% → 5.77% → 5.19% → 2.39% → 2.04%). However, high drop-out rate and poor information management have been identified as particular problems which now need to be addressed. Furthermore, client drop-out from MMT programs may reflect social issues the clients encounter, and consequently, sustainable MMT development requires incorporation of social measures that help MMT clients return to society without discrimination, especially through family cooperation and employment opportunities.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24188659 PMCID: PMC4176141 DOI: 10.1186/1747-597X-8-38
Source DB: PubMed Journal: Subst Abuse Treat Prev Policy ISSN: 1747-597X
Figure 1Policy framework of MMT in China.
Figure 2The clinical protocol in the MMT clinics in Hubei province, China.
Numbers of MMT clinics and patients treated in 2007–2011, Hubei province, China
| 2007 | 13 | 4674 | 5918 | 78 | 4070 |
| 2008 | 32 | 11153 | 15335 | 4329 | 5960 |
| 2009 | 42 | 9831 | 17883 | 9151 | 6741 |
| 2010 | 46 | 7936 | 11471 | 3970 | 5242 |
| 2011 | 49 | 8115 | 12223 | 4276 | 4916 |
HIV/AIDS cases and the percent distribution in 2007–2011, Hubei province, China
| Injection drug use | 44 | 12.12 | 33 | 5.77 | 31 | 5.19 | 20 | 2.39 | 18 | 2.04 |
| Heterosexual behavior | 141 | 38.84 | 253 | 44.23 | 252 | 42.21 | 412 | 49.28 | 470 | 53.17 |
| Homosexual behavior | 19 | 5.23 | 126 | 22.03 | 188 | 31.49 | 338 | 40.43 | 369 | 41.74 |
| Sexual and injection drug use | 0 | 0.00 | 1 | 0.17 | 3 | 0.50 | 2 | 0.24 | 0 | 0 |
| Blood/plasma collection | 20 | 5.51 | 55 | 9.62 | 13 | 2.18 | 16 | 1.91 | 8 | 0.90 |
| Blood/blood products transfusion | 39 | 10.74 | 26 | 4.55 | 23 | 3.85 | 9 | 1.08 | 7 | 0.79 |
| Mother-to-child transmission | 8 | 2.20 | 7 | 1.22 | 3 | 0.50 | 6 | 0.72 | 5 | 0.57 |
| Occupational exposure | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Others | 92 | 25.34 | 71 | 12.41 | 84 | 14.08 | 33 | 3.95 | 7 | 0.79 |
| Total | 363 | 572 | 597 | 836 | 884 | |||||